Increase of ATP-sensitive potassium (K ATP) channels in the heart of type-1 diabetic rats

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Chen, Zhih Cherng ^a,d   Cheng, Yung Ze ^a   Chen, Li Jen ^b   Cheng, Kai Chun ^c   Li, Yin X ^c   Cheng, Juei T ^a,b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

Author keywords

Cardiac atp sensitive potassium channel; Diabetic rats; Gene expression; Insulin; Phlorizin

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; DEOXYGLUCOSE; DIAZOXIDE; INSULIN; MESSENGER RNA; PHLORIZIN; ABC TRANSPORTER; ANTIDIABETIC AGENT; DRUG RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SCAVENGER; STREPTOZOCIN; SULFONYLUREA RECEPTOR; TIRON;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CONTROLLED STUDY; GENE EXPRESSION; HEART CELL CULTURE; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CELL; HEART RATE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEWBORN; NONHUMAN; NORTHERN BLOTTING; PROTEIN FUNCTION; RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ANIMAL; BLOOD PRESSURE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOPHYSIOLOGY; TIME; UPREGULATION; WISTAR RAT;

1,2-DIHYDROXYBENZENE-3,5-DISULFONIC ACID DISODIUM SALT; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD GLUCOSE; BLOOD PRESSURE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIAZOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FREE RADICAL SCAVENGERS; HEART RATE; HYPOGLYCEMIC AGENTS; INSULIN; KATP CHANNELS; MALE; MYOCYTES, CARDIAC; PHLORHIZIN; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, WISTAR; RECEPTORS, DRUG; RNA, MESSENGER; STREPTOZOCIN; TIME FACTORS; UP-REGULATION;

EID: 84855896567     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-8     Document Type: Article

References (32)

1. Sobel BE, Schneider DJ. Cardiovascular complications in diabetes mellitus. Curr Opin Pharmacol 2005, 5:143-148. 10.1016/j.coph.2005.01.002, 15780822.
2. De Angelis K, Schaan BD, Maeda CY, Dall'Ago P, Wichi RB, Irigoyen MC. Cardiovascular control in experimental diabetes. Braz J Med Biol Res 2002, 35:1091-1100. 10.1590/S0100-879X2002000900010, 12219181.
3. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature 1983, 305:147-148. 10.1038/305147a0, 6310409.
4. Wilde AA, Escande D, Schumacher CA, Thuringer D, Mestre M, Fiolet JW, Janse MJ. Potassium accumulation in the globally ischemic mammalian heart. A role for the ATP-sensitive potassium channel. Circ Res 1990, 67:835-843.
5. Zhang H, Flagg TP, Nichols CG. Cardiac sarcolemmal K(ATP) channels: Latest twists in a questing tale!. J Mol Cell Cardiol 2010, 48:71-75. 10.1016/j.yjmcc.2009.07.002, 2813340, 19607836.
6. Chan KW, Wheeler A, Csanady L. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition. J Gen Physiol 2008, 131:43-58. 2174157, 18079561.
7. Venkatesh N, Lamp ST, Weiss JN. Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. Circ Res 1991, 69:623-637.
8. Cole WC, McPherson CD, Sontag D. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991, 69:571-581.
9. Lee TM, Lin MS, Chang NC. Effect of ATP-sensitive potassium channel agonists on ventricular remodeling in healed rat infarcts. J Am Coll Cardiol 2008, 51:1309-1318. 10.1016/j.jacc.2007.11.067, 18371564.
10. O'Rourke B, Ramza BM, Marban E. Oscillations of membrane current and excitability driven by metabolic oscillations in heart cells. Science 1994, 265:962-966. 10.1126/science.8052856, 8052856.
11. Philip-Couderc P, Tavares NI, Roatti A, Lerch R, Montessuit C, Baertschi AJ. Forkhead transcription factors coordinate expression of myocardial KATP channel subunits and energy metabolism. Circ Res 2008, 102:e20-35. 10.1161/CIRCRESAHA.107.166744, 18202312.
12. Santos RM, Barbosa RM, Antunes CM, Silva AM, Salgado AP, Abrunhosa AJ, Pereira FC, Seica RM, Rosario LM. Bursting electrical activity generated in the presence of KATP channel blockers. Pharmacology, sensitivity to intracellular pH and modulation by glucose metabolism. Adv Exp Med Biol 1997, 426:33-41.
13. Moritz W, Leech CA, Ferrer J, Habener JF. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells. Endocrinology 2001, 142:129-138. 10.1210/en.142.1.129, 11145575.
14. Simpson P, McGrath A, Savion S. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res 1982, 51:787-801.
15. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974, 34:29-34. 10.1016/0002-9149(74)90089-7, 4835750.
16. Suzuki M, Saito T, Sato T, Tamagawa M, Miki T, Seino S, Nakaya H. Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice. Circulation 2003, 107:682-685. 10.1161/01.CIR.0000055187.67365.81, 12578868.
17. Liu IM, Tzeng TF, Tsai CC, Lai TY, Chang CT, Cheng JT. Increase in adenosine A1 receptor gene expression in the liver of streptozotocin-induced diabetic rats. Diabetes Metab Res Rev 2003, 19:209-215. 10.1002/dmrr.369, 12789654.
18. Tong YC, Chin WT, Cheng JT. Alterations in urinary bladder M2-muscarinic receptor protein and mRNA in 2-week streptozotocin-induced diabetic rats. Neurosci Lett 1999, 277:173-176. 10.1016/S0304-3940(99)00871-X, 10626841.
19. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-Velazquez R, Chen S, Rodriguez-Puyol M, Ziyadeh FN, Rodriguez-Puyol D. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 2001, 59:87-95. 10.1046/j.1523-1755.2001.00469.x, 11135061.
20. Cheng JT, Huang CC, Liu IM, Tzeng TF, Chang CJ. Novel mechanism for plasma glucose-lowering action of metformin in streptozotocin-induced diabetic rats. Diabetes 2006, 55:819-825. 10.2337/diabetes.55.03.06.db05-0934, 16505249.
21. Kain V, Kumar S, Sitasawad S. Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis. Cardiovasc Diabetol 2011, 10:97. 10.1186/1475-2840-10-97, 3234183, 22054019.
22. Ku PM, Chen LJ, Liang JR, Cheng KC, Li YX, Cheng JT. Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility. Cardiovasc Diabetol 2011, 10:57. 10.1186/1475-2840-10-57, 3141394, 21702924.
23. Eppens MC, Craig ME, Cusumano J, Hing S, Chan AK, Howard NJ, Silink M, Donaghue KC. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 2006, 29:1300-1306. 10.2337/dc05-2470, 16732012.
24. Gando S, Hattori Y, Akaishi Y, Nishihira J, Kanno M. Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation. J Pharmacol Exp Ther 1997, 282:475-484.
25. Maeda CY, Fernandes TG, Timm HB, Irigoyen MC. Autonomic dysfunction in short-term experimental diabetes. Hypertension 1995, 26:1100-1104.
26. Sanyal SN, Arita M, Ono K. Inhomogeneous derangement of cardiac autonomic nerve control in diabetic rats. Circ J 2002, 66:283-288. 10.1253/circj.66.283, 11922279.
27. Gross GJ, Fryer RM. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res 1999, 84:973-979.
28. Koya D. [Molecular understanding of adverse effects of hyperglycemia in diabetic nephropathy]. Nippon Jinzo Gakkai Shi 2007, 49:470-473.
29. Thackeray JT, Parsa-Nezhad M, Kenk M, Thorn SL, Kolajova M, Beanlands RS, DaSilva JN. Reduced CGP12177 binding to cardiac beta-adrenoceptors in hyperglycemic high-fat-diet-fed, streptozotocin-induced diabetic rats. Nucl Med Biol 2011, 38:1059-1066. 10.1016/j.nucmedbio.2011.04.002, 21831645.
30. Bucking C, Wood CM. Renal regulation of plasma glucose in the freshwater rainbow trout. J Exp Biol 2005, 208:2731-2739. 10.1242/jeb.01668, 16000542.
31. Cooper ME. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease. Am J Hypertens 2004, 17:31S-38S. 10.1016/j.amjhyper.2004.08.021, 15607433.
32. Mentink CJ, Kilhovd BK, Rondas-Colbers GJ, Torjesen PA, Wolffenbuttel BH. Time course of specific AGEs during optimised glycaemic control in type 2 diabetes. Neth J Med 2006, 64:10-16.